Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W +7 more
europepmc +1 more source
A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. [PDF]
Lin CH +9 more
europepmc +1 more source
MMP14 as a central mediator of TGF-β1-induced extracellular matrix remodeling in graves' orbitopathy. [PDF]
Wang X +6 more
europepmc +1 more source
Statin Use and the Risk of Developing Graves' Orbitopathy in Patients With Graves' Disease: A Systematic Review and Meta-Analysis With Regional and Gender-Stratified Analyses. [PDF]
Kermaj M +4 more
europepmc +1 more source
[New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review]. [PDF]
Kozlov ED +3 more
europepmc +1 more source
Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]
Abounoori M +5 more
europepmc +1 more source
Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]
Alfutaisi A +6 more
europepmc +1 more source
Related searches:
Neuroimaging of Graves’ orbitopathy
Best Practice & Research Clinical Endocrinology & Metabolism, 2012Neuroimaging of Graves' orbitopathy (GO) plays an important role in the differential diagnosis and interdisciplinary management of patients with GO. Orbital imaging is required in unclear or asymmetric proptosis, in suspected optic neuropathy and prior to decompression surgery. Especially computed tomography and magnetic resonance (MR) imaging show the
Wibke, Müller-Forell, George J, Kahaly
openaire +2 more sources

